Ribo Guo

2.9k total citations
18 papers, 1.2k citations indexed

About

Ribo Guo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ribo Guo has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Ribo Guo's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Protein Tyrosine Phosphatases (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Ribo Guo is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Protein Tyrosine Phosphatases (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Ribo Guo collaborates with scholars based in United States, China and Poland. Ribo Guo's co-authors include Dajun Yang, Shaomeng Wang, Peter P. Roller, Manchao Zhang, Bihua Li, York Tomita, Yan Ling, Terrence R. Burke, Xueliang Fang and Zengjian Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLANT PHYSIOLOGY.

In The Last Decade

Ribo Guo

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ribo Guo United States 14 904 261 193 136 119 18 1.2k
Xihan Wu China 16 781 0.9× 249 1.0× 275 1.4× 63 0.5× 119 1.0× 35 1.1k
Huameng Li United States 15 417 0.5× 335 1.3× 95 0.5× 143 1.1× 182 1.5× 19 946
Xuewei Wu China 15 693 0.8× 212 0.8× 463 2.4× 111 0.8× 54 0.5× 28 1.3k
Stig K. Hansen United States 13 1.1k 1.2× 153 0.6× 73 0.4× 239 1.8× 59 0.5× 19 1.3k
Sven Branner Denmark 17 1.0k 1.1× 513 2.0× 143 0.7× 404 3.0× 51 0.4× 27 1.5k
Richard F. Camalier United States 14 884 1.0× 229 0.9× 253 1.3× 66 0.5× 47 0.4× 21 1.5k
Yongxia Zhu China 20 798 0.9× 313 1.2× 170 0.9× 116 0.9× 26 0.2× 64 1.3k
Jean‐Marc Barret France 20 905 1.0× 375 1.4× 225 1.2× 59 0.4× 37 0.3× 43 1.3k
Raghavendra Gowda United States 20 695 0.8× 248 1.0× 115 0.6× 165 1.2× 25 0.2× 37 1.2k
Kiyohiro Nishikawa Japan 21 767 0.8× 397 1.5× 348 1.8× 88 0.6× 41 0.3× 56 1.4k

Countries citing papers authored by Ribo Guo

Since Specialization
Citations

This map shows the geographic impact of Ribo Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ribo Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ribo Guo more than expected).

Fields of papers citing papers by Ribo Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ribo Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ribo Guo. The network helps show where Ribo Guo may publish in the future.

Co-authorship network of co-authors of Ribo Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ribo Guo. A scholar is included among the top collaborators of Ribo Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ribo Guo. Ribo Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhao, Lichao, et al.. (2021). Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma. SHILAP Revista de lepidopterología. 1 indexed citations
2.
Chen, Yaoyu, Jinyun Chen, Alice Loo, et al.. (2013). Targeting HSF1 sensitizes cancer cells to HSP90 inhibition. Oncotarget. 4(6). 816–829. 49 indexed citations
3.
Scholer‐Dahirel, Alix, Michael R. Schlabach, Alice Loo, et al.. (2011). Maintenance of adenomatous polyposis coli ( APC )-mutant colorectal cancer is dependent on Wnt/β-catenin signaling. Proceedings of the National Academy of Sciences. 108(41). 17135–17140. 85 indexed citations
4.
Zhang, Manchao, Xueliang Fang, Hongpeng Liu, et al.. (2007). Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells. Cancer Letters. 252(2). 244–258. 8 indexed citations
5.
Jin, Xingyi, Dana R. Gossett, Shaomeng Wang, et al.. (2004). Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells. British Journal of Cancer. 91(10). 1808–1812. 62 indexed citations
6.
Nikolovska‐Coleska, Zaneta, Liang Xu, Zengjian Hu, et al.. (2004). Discovery of Embelin as a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure Database. Journal of Medicinal Chemistry. 47(10). 2430–2440. 285 indexed citations
7.
Long, Ya-Qiu, et al.. (2003). Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain. Biochemical and Biophysical Research Communications. 310(2). 334–340. 8 indexed citations
8.
Zhang, Manchao, Ribo Guo, Yifan Zhai, & Dajun Yang. (2003). LIGHT sensitizes IFNγ-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members. Cancer Letters. 195(2). 201–210. 41 indexed citations
9.
Zhang, Manchao, Ribo Guo, Yifan Zhai, Xin-Yuan Fu, & Dajun Yang. (2003). Light stimulates IFNγ-Mediated intercellular adhesion molecule-1 upregulation of cancer cells. Human Immunology. 64(4). 416–426. 10 indexed citations
10.
Zhang, Manchao, Hongpeng Liu, Ribo Guo, et al.. (2003). Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochemical Pharmacology. 66(1). 93–103. 162 indexed citations
11.
Li, Bihua, et al.. (2002). Development of a Phosphatase-Stable Phosphotyrosyl Mimetic Suitably Protected for the Synthesis of High-Affinity Grb2 SH2 Domain-Binding Ligands. Bioorganic & Medicinal Chemistry Letters. 12(19). 2781–2784. 15 indexed citations
12.
Gao, Yang, Kyeong Lee, Ribo Guo, et al.. (2002). Macrocyclization in the Design of Grb2 SH2 Domain-Binding Ligands Exhibiting High Potency in Whole-Cell Systems. Journal of Medicinal Chemistry. 46(2). 244–254. 32 indexed citations
13.
Enyedy, Istvan, Yan Ling, Kassoum Nacro, et al.. (2001). Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer Screening. Journal of Medicinal Chemistry. 44(25). 4313–4324. 243 indexed citations
14.
Burke, Terrence R., Zhu-Jun Yao, Yang Gao, et al.. (2001). N-Terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding. Bioorganic & Medicinal Chemistry. 9(6). 1439–1445. 18 indexed citations
15.
Gao, Yang, Li Wu, Ribo Guo, et al.. (2000). Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains. Bioorganic & Medicinal Chemistry Letters. 10(9). 923–927. 39 indexed citations
16.
Gao, Yang, Zhu-Jun Yao, Ribo Guo, et al.. (2000). Inhibition of Grb2 SH2 Domain Binding by Non-Phosphate-Containing Ligands. 2. 4-(2-Malonyl)phenylalanine as a Potent Phosphotyrosyl Mimetic. Journal of Medicinal Chemistry. 43(5). 911–920. 46 indexed citations
17.
Burke, Terrence R., Zhu-Jun Yao, Yang Gao, et al.. (1999). Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(3). 347–352. 28 indexed citations
18.
Guo, Ribo, Meizhong Luo, & Jon D. Weinstein. (1998). Magnesium-Chelatase from Developing Pea Leaves1. PLANT PHYSIOLOGY. 116(2). 605–615. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xihan Wu Breakdown of academic impact, for papers by Huameng Li Breakdown of academic impact, for papers by Xuewei Wu Breakdown of academic impact, for papers by Stig K. Hansen Breakdown of academic impact, for papers by Sven Branner Breakdown of academic impact, for papers by Richard F. Camalier Breakdown of academic impact, for papers by Yongxia Zhu Breakdown of academic impact, for papers by Jean‐Marc Barret Breakdown of academic impact, for papers by Raghavendra Gowda Breakdown of academic impact, for papers by Kiyohiro Nishikawa
Rankless by CCL
2026